Option chain shows key data for ZSPACE's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for ZSPACE.

ZSPACE (NASDAQ:ZSPC) Stock, Option Chain

ZSPACE Inc is a provider of augmented reality (AR) and virtual reality (VR) educational technology solutions. It focus on both United States K-12 schools and Career & Technical Education (CTE) markets. The company's proprietary hardware and software platform provides the ability to deliver an interactive, stereoscopic three-dimensional (3D) learning experience to users without the need to utilize VR goggles or specialty glasses. The platform serves a broad range of critical educational tools designed for K-12 science, technology, engineering and math (STEM) lessons as well as training skilled trades in areas such as health sciences, automotive engineering/repair, Unity3D software programming and manufacturing. Key revenue is generated from hardware.

Amazon, Crowdstrike, Autodesk, Dell, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Intraday Update

Markets

Movers

Trading Ideas

ACAD

EXTO

FTAI

GDEV

SPNT

ZSPC

Acadia Pharmaceuticals, FTAI Aviation And Other Big Stocks Moving Higher On Tuesday

Wall-Street-ai7-1

Earnings

Equities

Eurozone

AILE

EXOD

GXAI

Dow Dips Over 500 Points; US Goods Trade Deficit Widens In November

wall street christmas unsplash

Commodities

ALBT

MYNA

ORIS

Nasdaq Surges Over 100 Points; US Economy Adds 227,000 Jobs

ZSPACE Inc

WIIM

ITCI

Intra-Cellular Therapies shares are trading sharply higher after Johnson & Johnson agreed to acquire the company for $132.00 per share in cash.

LULU

Lululemon shares are trading higher after the company raised its Q4 guidance

lululemon athletica inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) today announced that, for the fourth quarter of fiscal 2024, the Company now expects net revenue will be in the range of $3.560 billion to $3.580 billion, representing growth of 11% to 12% compared to the fourth quarter of fiscal 2023, or growth of 6% to 7% excluding the 53rd week of 2024. The previous guidance range was $3.475 billion to $3.510 billion.
Diluted earnings per share are now expected to be in the range of $5.81 to $5.85 for the fourth quarter of fiscal 2024 compared to the Company's previous guidance range of $5.56 to $5.64.
The Company now expects gross margin to increase approximately 30 basis points relative to the fourth quarter of fiscal 2023, compared to its previous guidance of a decrease of 20 to 30 basis points. It now expects deleverage of selling, general, and administrative expenses of 80 to 90 basis points relative to the fourth quarter of fiscal 2023 compared to its previous guidance of deleverage of 90 to 100 basis points. There is no change to the Company's previous guidance for the effective tax rate.

Guidance

Lululemon Athletica Expects Q4 Revenue Of $3.56B-$3.58B (Prior $3.475B-$3.510B) Vs $3.517B Est, EPS Of $5.81-$5.85 (Prior $5.56-$5.64) Vs $5.66 Est

U.S. stock futures declined on Monday following Friday&#8217;s steep fall. Futures of all four major indices fell in premarket trade.
Friday&#8217;s decline followed a strong upmove in yields as the economy added 256,000 jobs in December, much above the economists&#8217; forecast of 165,000 jobs, the strongest since May 2024.
Traders now await the consumer price inflation data this week on Wednesday, which will further clear the case for the Fed to pause the rate cuts.
The 10-year and two-year Treasury notes yielded 4.78% and 4.42%, respectively. The probability of having no change in the interest rates for the upcoming Jan. 31, 2025 decision was at 97.3%, according to CME Group&#8217;s FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-1.27%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.86%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.38%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.21%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Monday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was down 0.76% to $576.10&nbsp;and the Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) dropped 1.16% to $501.35, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Wall Street suffered significant losses last week, erasing all gains since the election. This was primarily driven by a robust jobs report, which increased concerns about persistent inflation and further interest rate hikes by the Federal Reserve. The week&#8217;s trading was also impacted by rising geopolitical tensions and increased inflation expectations.
The session witnessed considerable losses among growth equities, particularly those with high valuations and exposure to interest rate sensitivity. This included semiconductor companies such as Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), as well as technology firms like Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>).
The Dow Jones Industrial Average closed 1.63% lower at 41,938.45, down approximately 697 points. The S&amp;P 500 Index fell 1.54% to 5,827.04, while the Nasdaq Composite dipped 1.63% to 19,161.63. Russell 200, on the other hand, fell 2.22% to 2,189.23.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-1.63%</td>
<td>19,161.63</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.54%</td>
<td>5,827.04</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.63%</td>
<td>41,938.45</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-2.22%</td>
<td>2,189.23</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
On <a href="https://www.benzinga.com/25/01/42939374/as-bond-yields-near-the-crucial-5-mark-last-seen-briefly-in-2023-and-global-financial-crisis-this-analyst-says-market-appears-to-be-overreacting">Friday</a>, the U.S. 30-year Treasury yielded 4.950% by the end of the trading session, however, it touched a high of 5.005% intraday. The 10-year Treasury, on the other hand, yielded an intraday high of 4.790% to settle at 4.762% on Friday.
&#8220;It is most likely that the pressure on interest rates is being driven by inflation fears from the soon-to-be-announced tariffs that Trump 2.0 will bring.&#8221; said Louis Navellier, the chairman and founder of Navellier &amp; Associates. &#8220;The market appears to be overreacting,&#8221; he added.
Ed Yardeni and Eric Wallerstein in their note called &#8216;Bond Vigilantes Spoking Stock Jockey&#8217; said, &#8220;If Tuesday&#8217;s CPI inflation rate for December is higher than expected, causing the 10-year Treasury bond yield to revisit 2023&#8217;s high of 5.00%.&#8221;
As the stocks struggled after Friday&#8217;s reports and bond yields&#8217; reaction, Yardeni and Navellier said that this dip was a buying opportunity.
Navellier said that the market could be additionally reacting to the uncertainty on what the Fed may do. Stocks, however, are taking the higher yields to heart, he added, saying &#8220;There&#8217;s no reason to panic.&#8221; as the pullback on higher rates is likely a &#8220;buying opportunity unless earnings disappoint.&#8221;
Yardeni also reiterated its forecast of 7,000 points on the S&amp;P 500 by the end of the year. &#8220;We still believe that the 10-year Treasury bond yield should trade mostly between 4.25% and 4.75% this year. So we think that the selloffs in the stock and bond markets are buying opportunities.&#8221;
Carson Research&#8217;s VP and global macro strategist, Sonu Varghese in a blog post said that it's not useful to read too much into market moves, especially short-term ones.
He argues that the interest rates are higher because the market likely thinks stronger job creation and economy, will put more upward pressure on inflation, which means the Federal Reserve will have to pause on rate cuts. &#8220;Markets are now expecting just one rate cut in 2025 (with a probability of under 25% for a second one) and don't expect it to happen before June,&#8217; he added.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
<ul>
<li>On Monday, the data for December&#8217;s monthly U.S. federal budget will be released at 2:00 p.m., ET.</li>
</ul>
<ul>
<li>On Tuesday, NFIB optimism index for December will be released at 6:00 a.m., ET.</li>
</ul>
<ul>
<li>December&#8217;s headline and core producer price index data will be announced at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Kansas City Fed President Jeffrey Schmid will be speaking at 10:00 a.m. ET.</li>
</ul>
<ul>
<li>Fed will release its Beige Book at 2:00 p.m., ET.</li>
</ul>
<ul>
<li>New York Fed President Williams will deliver his opening remarks on the policy at 3:05 p.m., ET.</li>
</ul>
<ul>
<li>On Wednesday, the headline and core consumer price index for December and the Empire State manufacturing survey data for January will be announced at 8:30 a.m., ET.</li>
</ul>
<ul>
<li> Richmond Fed President Barkin will speak at 9:00 a.m., ET.</li>
</ul>
<ul>
<li>New York Fed President Williams will speak at 11:00 a.m., ET.</li>
</ul>
<ul>
<li>Chicago Fed President Goolsbee will speak at 12:00 p.m., ET.</li>
</ul>
<ul>
<li>On Thursday, initial jobless claims till Jan. 11 will be released at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>December&#8217;s U.S. retail sales, import price index and Philadelphia Fed manufacturing survey will be announced at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Business inventory data for November and the Home builder confidence index for January will be released at 10:00 a.m., ET.</li>
</ul>
<ul>
<li>On Friday, housing starts and building permits data for December will be released at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>The industrial production and capacity utilization for December will be announced at 9:15 a.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Comtech Telecommunications Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMTL#NASDAQ">CMTL</a>) was up 10.17% in premarket ahead of its earnings before the opening bell. Analysts expect a quarterly loss of 16 cents per share on revenue of $125.53 million.</li>
</ul>
<ul>
<li>WD-40 Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) was up 2.48% after it posted better-than-expected results for its first quarter and reiterated its FY25 guidance on Friday.</li>
</ul>
<ul>
<li>KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) was down 0.76% ahead of its earnings, which is slated to be reported after the market closes. Analysts expect quarterly earnings of $2.45 per share on revenue of $1.99 billion.</li>
</ul>
<ul>
<li>Nordstrom Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) was up 0.12% after the company said that its net sales rose 4.9%, while comparable sales increased 5.8% for the nine-week holiday period ended Jan. 4.</li>
</ul>
<ul>
<li>Rigetti Computing Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) was down 16.01%, Quantum Computing Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) declined 7.91%, D-Wave Quantum Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) slipped 14.21% and IONQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) fell 14.51% in premarket after CNBC&#8217;s Jim Cramer <a href="https://www.benzinga.com/markets/equities/25/01/42890014/jim-cramer-warns-on-quantum-stories-as-stocks-plunge-we-need-you-out-before-the-froth-goes-away">highlighted</a> the speculative nature of nuclear and quantum computing stocks and advised investors to be cautious and realistic about the potential for short-term gains. </li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were higher in the early New York session by 1.76% to hover around $77.08 per barrel.
The gold spot index was down by 0.36% to $2,705.01 per ounce. The Dollar Index was up 0.34% at the 110.02 level.
Asian markets closed lower on Monday as Hong Kong&#8217;s Hang Seng, Japan&#8217;s Nikkei 225, India&#8217;s S&amp;P BSE Sensex, China&#8217;s CSI 300, Australia&#8217;s ASX 200, and South Korea&#8217;s Kospi index declined. European markets were also trading lower.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/01/42938954/michael-saylors-microstrategy-faces-risk-if-mstrs-0-convertible-bond-lenders-recall-non-recourse-loans-due-to-covenant-breach-heres-what-it-means-for-investors">Michael Saylor&#8217;s MicroStrategy Faces Risk If MSTR&#8217;s 0% Convertible Bond Lenders Recall Non-Recourse Loans Due To Covenant Breach: Here&#8217;s What It Means For Investors </a></li>
</ul>
Image Via Shutterstock

Analyst Color

Market Summary

Broad U.S. Equity ETFs

Futures

Pre-Market Outlook

Analyst Ratings

ETFs

General

ABTS

CMTL

IONQ

NVDA

PLTR

QBTS

QUBT

RGTI

WDFC

US Stock Futures Indicate Lower Opening On Monday After Last Week's Steep Fall: Analyst Says It's A 'Buying Opportunity,' But Market May Dip Further If This Happens

Johnson & Johnson Agrees To Acquire Intra-cellular Therapies For $132.00 Per Share In Cash For Total Equity Value Of $14.6B

Large Cap

Health Care

Johnson & Johnson Has Agreed To Acquire Intra-cellular Therapies For $132.00 Per Share In Cash For A Total Equity Value Of Approximately $14.6B

HC Wainwright &amp; Co. analyst Scott Buck reiterates SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) with a Buy and maintains $26 price target.

Price Target

Reiteration

SOUN

HC Wainwright & Co. Reiterates Buy on SoundHound AI, Maintains $26 Price Target

Citigroup analyst Andrew Kaplowitz reinstates Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) with a Buy and announces $37 price target.

Initiation

Citigroup Reinstates Buy on Symbotic, Announces $37 Price Target

KBR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBR#NYSE">KBR</a>) announced today it has been awarded a global agreement by BP International Limited (bp) for engineering, procurement and construction management (EPCM) services.
&nbsp;
Under the terms of the contract, KBR will provide EPCM for onshore, offshore, greenfield and brownfield conventional energy projects and new energy sector projects worldwide for three years, with an option to extend for two additional years. Additionally, KBR provides bp with market-leading licensed technology solutions, demonstrating the depth and versatility of its capabilities.

KBR Secures Global EPCM Contract with BP for Conventional and New Energy Projects

Barclays analyst Saket Kalia downgrades Definitive Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) from Equal-Weight to Underweight and maintains the price target from $4 to $4.

Downgrades

Barclays Downgrades Definitive Healthcare to Underweight, Maintains Price Target to $4

Barclays analyst Brendan Lynch upgrades Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) from Equal-Weight to Overweight and lowers the price target from $117 to $104.

Upgrades

Barclays Upgrades Crown Castle to Overweight, Lowers Price Target to $104

BMO Capital analyst John Kim upgrades Essex Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESS#NYSE">ESS</a>) from Market Perform to Outperform and lowers the price target from $323 to $310.

BMO Capital Upgrades Essex Property Trust to Outperform, Lowers Price Target to $310

Barclays analyst Brendan Lynch downgrades Terreno Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRNO#NYSE">TRNO</a>) from Overweight to Equal-Weight and lowers the price target from $68 to $60.

TRNO

Barclays Downgrades Terreno Realty to Equal-Weight, Lowers Price Target to $60

Needham analyst Joseph Stringer reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $320 price target.

ALNY

Needham Reiterates Buy on Alnylam Pharmaceuticals, Maintains $320 Price Target

JP Morgan analyst Jeffrey Zekauskas upgrades Nutrien (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>) from Underweight to Neutral and raises the price target from $40 to $50.

JP Morgan Upgrades Nutrien to Neutral, Raises Price Target to $50

BMO Capital analyst James Thalacker initiates coverage on PG&amp;E (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>) with a Outperform rating and announces Price Target of $21.

BMO Capital Initiates Coverage On PG&E with Outperform Rating, Announces Price Target of $21

JP Morgan analyst Andrea Teixeira downgrades Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) from Overweight to Neutral and lowers the price target from $262 to $203.

JP Morgan Downgrades Constellation Brands to Neutral, Lowers Price Target to $203

BMO Capital analyst James Thalacker downgrades NextEra Energy Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) from Outperform to Market Perform and lowers the price target from $26 to $18.

BMO Capital Downgrades NextEra Energy Partners to Market Perform, Lowers Price Target to $18

Needham analyst Gil Blum reiterates Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) with a Hold.

FOLD

Needham Reiterates Hold on Amicus Therapeutics

Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) today announced positive results from the Phase 3 C-POST trial, which demonstrated that adjuvant treatment with PD-1 inhibitor Libtayo&#xAE; (cemiplimab) led to a statistically significant and clinically meaningful improvement in the primary endpoint of disease-free survival (DFS) in patients with high-risk cutaneous squamous cell carcinoma (CSCC) after surgery.

REGN

Regeneron's Libtayo Extends Disease-Free Survival in High-Risk Skin Cancer Patients After Surgery

U.S. IPO Weekly Recap: 2Q IPO Market Closes Out With Sizable Pricings And Pipeline Additions

IPO Roundup: zSpace, Actuate Therapeutics and more

IPO Roundup: Bicara Therapeutics, Kairos Pharma and more

IPO Roundup: Aureus Greenway, Peak Resources and more

U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window

Chinese digital textbook provider Jinxin Technology and San Jose education technology provider zSpace made their public debuts this week, as another slow IPO year approaches its end.

Jinxin Technology, ZSpace Make Public Debuts

09:48 EST zSpace (ZSPC), Inc. trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving...

zSpace, Inc. trading halted, volatility trading pause

09:53 EST zSpace (ZSPC), Inc. trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news....

zSpace, Inc. trading resumes

09:37 EST zSpace (ZSPC), Inc. trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news....

09:32 EST zSpace (ZSPC), Inc. trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving...

AACBU

AAMU

ACTU

ALISU

ALMS

APUS

ARTV

BCAX

BIOA

BMGL

CAPNU

CIIT

CLIK

CUPR

DIMR

DMAAU

DRIL

ELOG

EMTX

FFSHU

FLAI

GLXG

GTSG

HLXB

HSPTU

HVIIU

INHI

JUNS

KAPA

KYTX

LINE

LNKS

MGRT

MIMI

MSGY

NAMI

OMSE

OSTX

PLMKU

PMNT

POLEU

SLRA

SPAI

SPHA

SPHAU

SVCCU

TAVI

TAVIU

TBBB

TELO

TSX:MKR

TSX:RCT

TSX:SYH

TTAN

TWFG

VACHU

WBTN

YMAT

YSXT

ZBIO

IPOs

Press Releases

zSpace Announces Pricing of $9.4 Million Initial Public Offering

Afya

American Public Education, Inc. - Common Stock

American Public Education

Adtalem Global Education Inc. Common Stock

Adtalem Glb Education

Bright Horizons Family Solutions Inc. Common Stock

Bright Horizons Family

Chegg

Coursera

Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share

Youdao

Duolingo

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 10 Ordinary Share (Cayman Islands)

Comments

ZSPACE

ZSPACE (ZSPC) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga